Department of Pediatrics, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
Faculty of Clinical Engineering, Fujita Health University School of Health Sciences, Toyoake, Aichi, Japan.
J Med Virol. 2018 Oct;90(10):1636-1642. doi: 10.1002/jmv.25244. Epub 2018 Jul 10.
The objectives of the work are to elucidate the incidence and virological findings of chromosomally integrated human herpesvirus 6 (ciHHV-6) in Japanese population and to analyze an association between ciHHV-6 and the clinical manifestation of exanthema subitum (ES). Real-time polymerase chain reaction was performed to determine HHV-6 DNA loads in 2347 cord blood samples from healthy neonates (cohort A), febrile children less than 5 years old (cohort B), and hematopoietic cell transplant recipients (cohort C). CiHHV-6 was confirmed by detection of high copy numbers of viral DNA in somatic cells. The integration site was determined by fluorescent in situ hybridization analysis. In the ciHHV-6 subjects of cohorts A and B, HHV-6 antibody titers were measured, the history of ES was obtained, and the incidence of ES was compared with non-ciHHV-6 children without primary HHV-6B infection in the cohort B. CiHHV-6 was detected in 14 (0.60%) of the 2347 samples: A (6/1006, 0.60%), B (6/790, 0.76%), and C (2/551, 0.36%). The integration sites were on chromosome 22q in seven cases, Yp in two cases, and 17q and Xp in one case. No past history of ES was observed in 11 of the 12 subjects. Nine children with ciHHV-6 underwent serological analysis and were found to be positive for HHV-6 IgG antibodies. Incidence of ES was statistically higher in the control subjects than the ciHHV-6 subjects (P = 0.0039). In Japan, the frequency of ciHHV-6 was 0.60%. A high incidence of ciHHV-6A, specifically in chromosome 22, is a characteristic finding among the Japanese. CiHHV-6 may interfere with the clinical symptoms of primary HHV-6B infection.
本研究旨在阐明人疱疹病毒 6 型(HHV-6)整合入染色体(ciHHV-6)在日本人群中的发生率和病毒学特征,并分析 ciHHV-6 与幼儿急疹(ES)临床表现之间的相关性。采用实时聚合酶链反应(PCR)方法检测 2347 例健康新生儿(队列 A)、5 岁以下发热儿童(队列 B)和造血细胞移植受者(队列 C)脐带血样本中 HHV-6DNA 载量。通过检测体细胞中病毒 DNA 的高拷贝数来确定 ciHHV-6。通过荧光原位杂交分析确定整合位点。在队列 A 和 B 的 ciHHV-6 受试者中,检测 HHV-6 抗体滴度,获取 ES 病史,并与队列 B 中无原发性 HHV-6B 感染的非 ciHHV-6 儿童的 ES 发生率进行比较。在 2347 例样本中检测到 14 例(0.60%)ciHHV-6:A(6/1006,0.60%)、B(6/790,0.76%)和 C(2/551,0.36%)。七个病例的整合部位在 22q 染色体上,两个在 Yp 染色体上,一个在 17q 和 Xp 染色体上。12 例受试者中 11 例无 ES 既往病史。9 例 ciHHV-6 患儿行血清学分析,均为 HHV-6 IgG 抗体阳性。对照组 ES 发生率明显高于 ciHHV-6 组(P=0.0039)。在日本,ciHHV-6 的频率为 0.60%。ciHHV-6A 尤其是 22 号染色体上的高发生率是日本人的一个特征性发现。ciHHV-6 可能干扰原发性 HHV-6B 感染的临床症状。